Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amanta HealthcareNSE:AMANTA +2.00%14 PB Ratio is 2.76 as of Aug. 14, 2026, which is 19% above its 10-year median of 2.31. GuruFocus rates NSE:AMANTA with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 919 Drug Manufacturers companies, Amanta Healthcare ranks worse than 63.44% on this metric.
The historical rank and industry rank for Amanta Healthcare's PB Ratio or its related term are showing as below:
NSE:AMANTA'
s PB Ratio Range Over the Past 10 Years
Min: 1.9 Med: 2.31 Max: 5.69
Current: 2.75
During the past 5 years, Amanta Healthcare's highest PB Ratio was 5.69. The lowest was 1.90. And the median was 2.31.
NSE:AMANTA's PB Ratio is ranked worse than 63.44% of 919
companies
in the Drug Manufacturers industry
Industry Median: 1.98
vs NSE:AMANTA: 2.75
During the past 12 months, Amanta Healthcare's average Book Value Per Share Growth Rate was 128.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 51.90% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Amanta Healthcare was 51.90% per year. The lowest was 14.10% per year. And the median was 33.00% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Amanta Healthcare PB Ratio Related Terms
Amanta Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Amanta Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amanta Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amanta Healthcare PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amanta Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Amanta Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Amanta Healthcare (NSE:AMANTA) has a PB Ratio of 2.76 as of Aug. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Amanta Healthcare and its competitors. This is 19% above median its historical median of 2.31. Over the past decade, Amanta Healthcare's PB Ratio has ranged from 1.90 to 5.69. According to the industry distribution chart, Amanta Healthcare ranks #583 out of 919 companies in the Drug Manufacturers industry, placing it in the top 63.4%.
Is Amanta Healthcare's PB Ratio too high?
Amanta Healthcare's current PB Ratio of 2.76 is 19% above median its 10-year median of 2.31. Over the past 10 years, this metric has ranged from a low of 1.90 to a high of 5.69. The Drug Manufacturers industry median PB Ratio is 1.98. Amanta Healthcare's value of 2.76 is 39.4% above this industry median. Based on the distribution chart, Amanta Healthcare ranks #583 out of 919 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Amanta Healthcare has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Amanta Healthcare ranks #583 out of 919 companies for PB Ratio. This places Amanta Healthcare in the lower half of its industry. The industry median PB Ratio is 1.98. Amanta Healthcare's value of 2.76 is 39.4% above this benchmark. Historically, Amanta Healthcare's own PB Ratio has ranged from 1.90 to 5.69 over the past decade. While the company's 10-year median is 2.31 vs. the industry median of 1.98, Amanta Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.98, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amanta Healthcare's current PB Ratio of 2.76 is 39.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Amanta Healthcare and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amanta Healthcare's current PB Ratio is 2.76, which is 19% above median its own 10-year median of 2.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current PB Ratio of 2.76. The current PB Ratio is 2.76, which is 19% above median its 10-year median of 2.31 and 39.4% above the Drug Manufacturers industry median of 1.98. Amanta Healthcare's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current PB Ratio is 2.76 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
14GF Score
Get the complete analysis for NSE:AMANTA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AMANTA has been successfully added to your 
